• 12717 Citations
  • 39 h-Index
1973 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2013

CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: A retrospective substudy of the HERA trial (BIG 1-01)

Pestalozzi, B. C., Holmes, E., de Azambuja, E., Metzger-Filho, O., Hogge, L., Scullion, M., Láng, I., Wardley, A., Lichinitser, M., Sanchez, R. I. L., Müller, V., Dodwell, D., Gelber, R. D., Piccart-Gebhart, M. J. & Cameron, D., Mar 1 2013, In : The Lancet Oncology. 14, 3, p. 244-248 5 p.

Research output: Contribution to journalArticle

78 Citations (Scopus)

Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27 - A randomized controlled phase III trial

Goss, P. E., Ingle, J. N., Pritchard, K. I., Ellis, M. J., Sledge, G. W., Budd, G. T., Rabaglio, M., Ansari, R. H., Johnson, D. B., Tozer, R., D'Souza, D. P., Chalchal, H., Spadafora, S., Stearns, V., Perez, E. A., Liedke, P. E. R., Lang, I., Elliott, C., Gelmon, K. A., Chapman, J. A. W. & 1 others, Shepherd, L. E., Apr 10 2013, In : Journal of Clinical Oncology. 31, 11, p. 1398-1404 7 p.

Research output: Contribution to journalArticle

148 Citations (Scopus)

Expert opinion 2011 on the use of new anti-resorptive agents in the prevention of skeletal-related events in metastatic bone disease

Anghel, R., Bachmann, A., Bekşac, M., Brodowicz, T., Finek, J., Komadina, R., Krzemieniecki, K., Lang, I., Marencak, J., Von Moos, R., Pecherstorfer, M., Rordorf, T., Vrbanec, D. & Zielinski, C., Aug 1 2013, In : Wiener Klinische Wochenschrift. 125, 15-16, p. 439-447 9 p.

Research output: Contribution to journalReview article

4 Citations (Scopus)

Preoperatív kemoterápia a colorectalis májáttétes betegek sebészi kezelésében

Translated title of the contribution: Preoperative chemotherapy in the surgical treatment of colorectal liver metastasesDede, K., Láng, I., Pörneczi, B., Mester, G., Fekete, A., Kőszegi, G., Mersich, T., Besznyák, I. & Bursics, A., Dec 1 2013, In : Magyar sebészet. 66, 6, p. 325-330 6 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Quality of life analysis in patients with KRAS wild-type metastatic colorectal cancer treated first-line with cetuximab plus irinotecan, fluorouracil and leucovorin

Láng, I., Köhne, C. H., Folprecht, G., Rougier, P., Curran, D., Hitre, E., Sartorius, U., Griebsch, I. & Van Cutsem, E., Jan 1 2013, In : European Journal of Cancer. 49, 2, p. 439-448 10 p.

Research output: Contribution to journalArticle

41 Citations (Scopus)

Successful treatment of solitary bone metastasis of non-small cell lung cancer with bevacizumab and hyperthermia

Rubovszky, G., Nagy, T., Gődény, M., Szász, A. & Láng, I., Jan 2013, In : Pathology and Oncology Research. 19, 1, p. 119-122 4 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)
6 Citations (Scopus)
2012

A hanging manover újabb indikációi a májsebészetben.

Translated title of the contribution: [Latest indications for hanging manoeuvre in liver surgery].Jakab, F., Dede, K., Láng, I., Bursics, A. & Mersich, T., Dec 2012, In : Magyar sebészet. 65, 6, p. 407-415 9 p.

Research output: Contribution to journalArticle

A pet/ct szerepe az emlörák diagnosztikájában és kezelésében - összefoglaló az eddig megszerzett ismeretekrõl és a kutatás további irányairól

Translated title of the contribution: Role of PET/CT in diagnosis and treatment of breast cancer - Review on present knowledge and current research trendsBalázs, M., Zsolt, H., István, L., Miklós, K. & Katalin, B., 2012, In : Magyar onkologia. 56, 1, p. 23-29 7 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

A phase II multicenter study of two different dosages of pemetrexed given in combination with cyclophosphamide as first-line treatment in patients with locally advanced or metastatic breast cancer

Dittrich, C., Solska, E., Manikhas, A., Eniu, A., Tjulandin, S., Anghel, R., Musib, L., Frimodt-Moller, B., Liu, Y., Krejcy, K. & Láng, I., May 1 2012, In : Cancer Investigation. 30, 4, p. 309-316 8 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Az emlorák korszeru gyógyszeres kezelése

Translated title of the contribution: Modern pharmacological therapy of breast cancerLáng, I., Kahán, Z., Hitre, E., Dank, M., Rubovszky, G., Horváth, Z. & Kásler, M., Jan 1 2012, In : Orvosi hetilap. 153, 2, p. 56-65 10 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Az emlorák korszeru képalkotó diagnosztikája: nukleárismedicina-technikák

Translated title of the contribution: Modern diagnostics of breast cancer: Nuclear medicine techniquesKatalin, B., István, S., Balázs, M., Zsolt, H., István, L. & Miklós, K., Jan 1 2012, In : Orvosi hetilap. 153, 1, p. 14-21 8 p.

Research output: Contribution to journalArticle

Az MR-vizsgálat szerepe a rectumcarcinomák terápiájának meghatározásában

Translated title of the contribution: Role of MRI in determining the therapy of rectal cancerJederán, É., Mátrai, Z., Tóth, L., Lövey, J., Láng, I., Hitre, E., Naszádos, G. & Godény, M., 2012, In : Magyar onkologia. 56, 3, p. 179-186 8 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab

Budai, B., Komlósi, V., Adleff, V., Pap, É., Réti, A., Nagy, T., Kralovánszky, J., Láng, I. & Hitre, E., Jan 1 2012, In : Pharmacogenetics and Genomics. 22, 1, p. 69-72 4 p.

Research output: Contribution to journalArticle

14 Citations (Scopus)

Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial

Ewertz, M., Gray, K. P., Regan, M. M., Ejlertsen, B., Price, K. N., Thürlimann, B., Bonnefoi, H., Forbes, J. F., Paridaens, R. J., Rabaglio, M., Gelber, R. D., Colleoni, M., Láng, I., Smith, I. E., Coates, A. S., Goldhirsch, A. & Mouridsen, H. T., Nov 10 2012, In : Journal of Clinical Oncology. 30, 32, p. 3967-3975 9 p.

Research output: Contribution to journalArticle

68 Citations (Scopus)

Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer

Lang, I., Inbar, M. J., Kahán, Z., Greil, R., Beslija, S., Stemmer, S. M., Kaufman, B., Zvirbule, Z., Steger, G. G., Messinger, D., Brodowicz, T. & Zielinski, C., Nov 1 2012, In : European Journal of Cancer. 48, 17, p. 3140-3149 10 p.

Research output: Contribution to journalArticle

11 Citations (Scopus)

Significance of histomorphology of early triple-negative breast cancer

Rubovszky, G., Horváth, Z., Tóth, E., Láng, I. & Kásler, M., Oct 1 2012, In : Pathology and Oncology Research. 18, 4, p. 823-831 9 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Vandetanib with docetaxel as second-line treatment for advanced breast cancer: A double-blind, placebo-controlled, randomized Phase II study

Boér, K., Láng, I., Llombart-Cussac, A., Andreasson, I., Vivanco, G. L., Sanders, N., Pover, G. M. & Murray, E., Apr 1 2012, In : Investigational New Drugs. 30, 2, p. 681-687 7 p.

Research output: Contribution to journalArticle

33 Citations (Scopus)
2011

A modern emlo{double acute}sebészet onkoplasztikai kihívásai

Translated title of the contribution: Oncoplastic challenges in modern breast surgeryMátrai, Z., Gulyás, G., Tóth, L., Polgár, C., Bidlek, M., Szabó, É., Láng, I., Horváth, Z., Udvarhelyi, N., Kunos, C., Sávolt, Á., Pesthy, P. & Kásler, M., 2011, In : Magyar onkologia. 55, 1, p. 40-52 13 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)

Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study

Colleoni, M., Giobbie-Hurder, A., Regan, M. M., Thürlimann, B., Mouridsen, H., Mauriac, L., Forbes, J. F., Paridaens, R., Láng, I., Smith, I., Chirgwin, J., Pienkowski, T., Wardley, A., Price, K. N., Gelber, R. D., Coates, A. S. & Goldhirsch, A., Mar 20 2011, In : Journal of Clinical Oncology. 29, 9, p. 1117-1124 8 p.

Research output: Contribution to journalArticle

101 Citations (Scopus)

A Phase II, open-label, randomised study to assess the efficacy and safety of the MEK1/2 inhibitor AZD6244 (ARRY-142886) versus capecitabine monotherapy in patients with colorectal cancer who have failed one or two prior chemotherapeutic regimens

Bennouna, J., Lang, I., Valladares-Ayerbes, M., Boer, K., Adenis, A., Escudero, P., Kim, T. Y., Pover, G. M., Morris, C. D. & Douillard, J. Y., Oct 1 2011, In : Investigational New Drugs. 29, 5, p. 1021-1028 8 p.

Research output: Contribution to journalArticle

93 Citations (Scopus)

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: The BIG 1-98 randomised clinical trial at 8·1 years median follow-up

Regan, M. M., Neven, P., Giobbie-Hurder, A., Goldhirsch, A., Ejlertsen, B., Mauriac, L., Forbes, J. F., Smith, I., Láng, I., Wardley, A., Rabaglio, M., Price, K. N., Gelber, R. D., Coates, A. S. & Thürlimann, B., Nov 1 2011, In : The Lancet Oncology. 12, 12, p. 1101-1108 8 p.

Research output: Contribution to journalArticle

264 Citations (Scopus)

Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: Updated analysis of overall survival according to tumor KRAS and BRAF mutation status

Van Cutsem, E., Köhne, C. H., Láng, I., Folprecht, G., Nowacki, M. P., Cascinu, S., Shchepotin, I., Maurel, J., Cunningham, D., Tejpar, S., Schlichting, M., Zubel, A., Celik, I., Rougier, P. & Ciardiello, F., May 20 2011, In : Journal of Clinical Oncology. 29, 15, p. 2011-2019 9 p.

Research output: Contribution to journalArticle

1259 Citations (Scopus)
5 Citations (Scopus)

Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A phase 2, randomised, double-blind, placebo-controlled study

Martin, M., Roche, H., Pinter, T., Crown, J., Kennedy, M. J., Provencher, L., Priou, F., Eiermann, W., Adrover, E., Lang, I., Ramos, M., Latreille, J., Jagiełło-Gruszfeld, A., Pienkowski, T., Alba, E., Snyder, R., Almel, S., Rolski, J., Munoz, M., Moroose, R. & 9 others, Hurvitz, S., Baños, A., Adewoye, H., Hei, Y. J., Lindsay, M. A., Rupin, M., Cabaribere, D., Lemmerick, Y. & Mackey, J. R., Apr 2011, In : The Lancet Oncology. 12, 4, p. 369-376 8 p.

Research output: Contribution to journalArticle

72 Citations (Scopus)

O{double acute}rszemnyirokcsomó-biopszia neoadjuváns kemoterápiát igénylo{double acute} emlo{double acute}rákoknál

Translated title of the contribution: Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancerMátrai, Z., Tóth, L., Polgár, C., Láng, I., Godény, M., Sinkovics, I., Horváth, Z., Bidlek, M., Udvarhelyi, N., Bartal, A., Sávolt, Á., Újhelyi, M. & Kásler, M., 2011, In : Magyar onkologia. 55, 2, p. 73-84 12 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer

Afzal, S., Gusella, M., Jensen, S. A., Vainer, B., Vogel, U., Andersen, J. T., Brødbæk, K., Petersen, M., Jimenez-Solem, E., Adleff, V., Budai, B., Hitre, E., Lng, I., Orosz, E., Bertolaso, L., Barile, C., Padrini, R., Kralovnszky, J., Pasini, F. & Poulsen, H. E., Sep 1 2011, In : Pharmacogenomics. 12, 9, p. 1257-1267 11 p.

Research output: Contribution to journalArticle

27 Citations (Scopus)

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial

Viale, G., Regan, M. M., Dell'Orto, P., Mastropasqua, M. G., Maiorano, E., Rasmussen, B. B., MacGrogan, G., Forbes, J. F., Paridaens, R. J., Colleoni, M., Láng, I., Thürlimann, B., Mouridsen, H., Mauriac, L., Gelber, R. D., Price, K. N., Goldhirsch, A., Gusterson, B. A. & Coates, A. S., Oct 2011, In : Annals of Oncology. 22, 10, p. 2201-2207 7 p.

Research output: Contribution to journalArticle

67 Citations (Scopus)
2010

A tripla-negatív emlokarcinóma - Irodalmi áttekintés

Translated title of the contribution: Triple negative breast carcinoma - Rewiev of current literatureRubovszky, G., Udvarhelyi, N., Horváth, Z., Láng, I. & Kásler, M., Dec 1 2010, In : Magyar onkologia. 54, 4, p. 325-335 11 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Az emloárák belgyógyászati onkológiai (gyógyszeres) kezelése

Láng, I., Kahán, Z., Pintér, T., Dank, M., Boér, K., Pajkos, G., Faluhelyi, Z., Pikó, B., Eckhardt, S. & Horváth, Z., Sep 1 2010, In : Magyar onkologia. 54, 3, p. 237-254 18 p.

Research output: Contribution to journalArticle

12 Citations (Scopus)

Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: The FLAGS trial

Ajani, J. A., Rodriguez, W., Bodoky, G., Moiseyenko, V., Lichinitser, M., Gorbunova, V., Vynnychenko, I., Garin, A., Lang, I. & Falcon, S., Mar 20 2010, In : Journal of Clinical Oncology. 28, 9, p. 1547-1553 7 p.

Research output: Contribution to journalArticle

426 Citations (Scopus)
2009

A Case-Control Study of Gallbladder Cancer in Hungary

Nakadaira, H., Lang, I., Szentirmay, Z., Hitre, E., Kaster, M. & Yamamoto, M., 2009, In : Asian Pacific Journal of Cancer Prevention. 10, 5, p. 833-836 4 p.

Research output: Contribution to journalArticle

11 Citations (Scopus)

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

Rabaglio, M., Sun, Z., Price, K. N., Castiglione-Gertsch, M., Hawle, H., Thürlimann, B., Mouridsen, H., Campone, M., Forbes, J. F., Paridaens, R. J., Colleoni, M., Pienkowski, T., Nogaret, J. M., Láng, I., Smith, I., Gelber, R. D., Goldhirsch, A. & Coates, A. S., Jan 1 2009, In : Annals of Oncology. 20, 9, p. 1489-1498 10 p.

Research output: Contribution to journalArticle

107 Citations (Scopus)
2008

A biszfo szfo nát-keze lés során és zlelhet o vese funkci ó-válto zás vizsg álata emlorákos betege inknél

Translated title of the contribution: Changes in renal function during bisphosphonate treatment of breast cancer patientsHorváth, Z., Farkas, P., Ganofszky, E., Hitre, E., Juhos, É., Nagy, T., Rubovszky, G., Szabó, E. & Láng, I., Dec 1 2008, In : Magyar onkologia. 52, 1, p. 49-55 7 p.

Research output: Contribution to journalArticle

Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial

Francis, P., Crown, J., Di Leo, A., Buyse, M., Balil, A., Andersson, M., Nordenskjöld, B., Lang, I., Jakesz, R., Vorobiof, D., Gutiérrez, J., Van Hazel, G., Dolci, S., Jamin, S., Bendahmane, B., Gelber, R. D., Goldhirsch, A., Castiglione-Gertsch, M. & Piccart-Gebhart, M., Jan 2008, In : Journal of the National Cancer Institute. 100, 2, p. 121-133 13 p.

Research output: Contribution to journalArticle

125 Citations (Scopus)

Az epidermális növekedési faktor recept orát célzó terápiák RAS paradoxona vastag- és végbélrákban

Translated title of the contribution: The RAS paradoxon of the EGFR-targeted therapy of colorectal cancerTímár, J. & Láng, I., Dec 1 2008, In : Magyar onkologia. 52, 2, p. 185-191 7 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Effect of genetic predisposition on the risk of gallbladder cancer in Hungary

Kimura, A., Tsuchiya, Y., Lang, I., Zoltan, S., Nakadaira, H., Ajioka, Y., Kiyohara, C., Oyama, M., Nakamura, K. & Yamamoto, M., 2008, In : Asian Pacific Journal of Cancer Prevention. 9, 3, p. 391-396 6 p.

Research output: Contribution to journalArticle

15 Citations (Scopus)

Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary

Nagahashi, M., Ajioka, Y., Lang, I., Szentirmay, Z., Kasler, M., Nakadaira, H., Yokoyama, N., Watanabe, G., Nishikura, K., Wakai, T., Shirai, Y., Hatakeyama, K. & Yamamoto, M., Jan 7 2008, In : World journal of gastroenterology. 14, 1, p. 70-75 6 p.

Research output: Contribution to journalArticle

46 Citations (Scopus)

Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015

Köhne, C. H., De greve, J., Hartmann, J. T., Lang, I., Vergauwe, P., Becker, K., Braumann, D., Joosens, E., Müller, L., Janssens, J., Bokemeyer, C., Reimer, P., Link, H., Späth-Schwalbe, E., Wilke, H. J., Bleiberg, H., Van den Brande, J., Debois, M., Bethe, U. & Van Cutsem, E., May 1 2008, In : Annals of Oncology. 19, 5, p. 920-926 7 p.

Research output: Contribution to journalArticle

124 Citations (Scopus)

Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup phase III BIG 02-98 trial

Pestalozzi, B. C., Francis, P., Quinaux, E., Dolci, S., Azambuja, E., Gelber, R. D., Viale, G., Balil, A., Andersson, M., Nordenskjöd, B., Gnant, M., Gutierrez, J., Láng, I., Crown, J. P. A. & Piccart-Gebhart, M., Nov 3 2008, In : Annals of Oncology. 19, 11, p. 1837-1841 5 p.

Research output: Contribution to journalArticle

15 Citations (Scopus)

Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: The BIG 1-98 trial

Crivellari, D., Sun, Z., Coates, A. S., Price, K. N., Thürlimann, B., Mouridsen, H., Mauriac, L., Forbes, J. F., Paridaens, R. J., Castiglione-Gertsch, M., Gelber, R. D., Colleoni, M., Láng, I., Del Mastro, L., Gladieff, L., Rabaglio, M., Smith, I. E., Chirgwin, J. H. & Goldhirsch, A., Jan 1 2008, In : Journal of Clinical Oncology. 26, 12, p. 1972-1979 8 p.

Research output: Contribution to journalArticle

114 Citations (Scopus)

Molekulárisan célzott biológiai terápia a szolid tumorok kezelésében II. Gastrointestinalis stromatumor, hasnyálmirigyrák, fej-nyak laphámrák, nem kissejtes tüdorák, veserák

Translated title of the contribution: Molecularly targeted biological therapy in the treatment of solid tumours part two - Gastrointestinal stromal tumour, pancreatic cancer, head and neck cancer, non-small cell lung cancer, kidney cancerIstván, L. & Erika, H., Jan 1 2008, In : Lege Artis Medicinae. 18, 1, p. 17-21 5 p.

Research output: Contribution to journalArticle

Progress on BIG 1-02/IBCSG 27-02/NSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer

Wapnir, I. L., Aebi, S., Gelber, S., Anderson, S. J., Láng, I., Robidoux, A., Mamounas, E. P. & Wolmark, N., Nov 1 2008, In : Annals of Surgical Oncology. 15, 11, p. 3227-3231 5 p.

Research output: Contribution to journalArticle

23 Citations (Scopus)

Sebészi onkológia

Translated title of the contribution: Surgical oncologyFerenc, J. & István, L., Dec 15 2008, In : Orvoskepzes. 83, 3, p. 281-285 5 p.

Research output: Contribution to journalReview article

2007

Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: Update of study BIG 1-98

Coates, A. S., Keshaviah, A., Thürlimann, B., Mouridsen, H., Mauriac, L., Forbes, J. F., Paridaens, R., Castiglione-Gertsch, M., Gelber, R. D., Colleoni, M., Láng, I., Del Mastro, L., Smith, I., Chirgwin, J., Nogaret, J. M., Pienkowski, T., Wardley, A., Jakobsen, E. H., Price, K. N. & Goldhirsch, A., Feb 10 2007, In : Journal of Clinical Oncology. 25, 5, p. 486-492 7 p.

Research output: Contribution to journalArticle

737 Citations (Scopus)

Molekulárisan célzott biológiai terápia a szolid tumorok kezelésében - 1. Emlorák és colorectalis rák

Translated title of the contribution: Molecularly targeted biological therapy in the treatment of solid tumours part one - Breast cancer and colorectal cancerIstván, L. & Erika, H., Sep 1 2007, In : Lege Artis Medicinae. 17, 8-9, p. 565-570 6 p.

Research output: Contribution to journalReview article

2 Citations (Scopus)

Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial

Mauriac, L., Keshaviah, A., Debled, M., Mouridsen, H., Forbes, J. F., Thürlimann, B., Paridaens, R., Monnier, A., Láng, I., Wardley, A., Nogaret, J. M., Gelber, R. D., Castiglione-Gertsch, M., Price, K. N., Coates, A. S., Smith, I., Viale, G., Rabaglio, M., Zabaznyi, N. & Goldhirsch, A., May 2007, In : Annals of Oncology. 18, 5, p. 859-867 9 p.

Research output: Contribution to journalArticle

112 Citations (Scopus)

Radio-guided resection of non-palpable rectal carcinoma following polypectomy

Mersich, T., Lang, I., Balogh, I. & Jakob, F., Apr 1 2007, In : Hepato-Gastroenterology. 54, 75, p. 751-752 2 p.

Research output: Contribution to journalArticle

2006

The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005

Van Cutsem, E., Dicato, M., Arber, N., Benson, A., Cunningham, D., Diaz-Rubio, E., Glimelius, B., Goldberg, R., Haller, D., Haustermans, K., Koo-Kang, Y., Labianca, R., Lang, I., Minsky, B., Nordlinger, B., Roth, A., Rougier, P., Schmoll, H. J., Sobrero, A., Tabernero, J. & 2 others, Szawlowski, A. & van de Velde, C., Jun 1 2006, In : Annals of Oncology. 17, SUPPL. 6, p. vi13-vi18

Research output: Contribution to journalArticle

26 Citations (Scopus)

Trastuzumab (Herceptin) a HER-2-pozitív korai emlorák adjuváns kezelésében

Translated title of the contribution: Trastuzumab (Herceptin) in the adjuvant teatment of HER-2-positive early breast cancerLáng, I. & Hitre, E., Dec 1 2006, In : Magyar onkologia. 50, 4, p. 293-302 10 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)